CAS 2109805-56-1

4-(2-Methyl-1-(4-methylpiperazin-1-yl)-1-oxopropan-2-yl)-N-(6-(pyridin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide

CAS: 2109805-56-1

Formel: C₂₈H₃₀N₆O₂

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 482.5768

Ref: IN-DA01V3MD

CLK-IN-T3

CAS: 2109805-56-1

CLK-IN-T3

Reinheit: ≥98%

Molekulargewicht: 482.58g/mol

Ref: 54-BUP04185

CLK-IN-T3

CAS: 2109805-56-1

CLK-IN-T3 is a small molecule that has been shown to induce apoptosis in cancer cells. CLK-IN-T3 induces the activation of caspase 3, which is involved in the execution phase of apoptosis. CLK-IN-T3 also synergizes with other chemotherapeutic agents, such as doxorubicin and vincristine, to induce cell death. CLK-IN-T3 has been shown to inhibit neurodevelopmental processes and enhances apoptotic signaling pathways in hCT116 colon cancer cells. This drug may be useful for combination strategies for cancer therapy.

Formel: C₂₈H₃₀N₆O₂

Reinheit: Min. 95%

Molekulargewicht: 482.6 g/mol

Ref: 3D-JJD80556

CLK-IN-T3

CAS: 2109805-56-1

CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity.

Formel: C₂₈H₃₀N₆O₂

Reinheit: 99.61%

Farbe und Form: Solid

Molekulargewicht: 482.58

Ref: TM-T14980